MedTrace Logo

Study to Evaluate the Efficacy and Safety of CKD-350

NCT02777723 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2016-05-19

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of CKD-350 in patients with dry eye syndrome

Conditions

  • Dry Eye Syndrome

Interventions

DRUG

Xenobella

Hypotonic 0.3% Sodium Hyaluronate

DRUG

Isotonic 0.3% Sodium Hyaluronate

Isotonic 0.3% Sodium Hyaluronate

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • HyoMyung Kim, MD · Korea University Anam Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-07-31
Completion
2016-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02777723 on ClinicalTrials.gov